Mountain View, CA, United States of America

Bing Zheng

This inventor holds 24 USPTO granted patents and 13 published patent applications, plus 2 CIPO patents and 12 EPO patents, primarily in Antibody Conjugates. Top assignees: Genentech, Inc., Genetech, Inc.. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bing Zheng. Retrieved from https://idiyas.com/inventor/bing-zheng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 197(Granted Patents)


Company Filing History:


Years Active: 2012-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Antibody-Drug Conjugates
Anti-CD79B
Anti-CLL-1
Immunoconjugates
Humanized Antibodies
Silvestrol
FcRH5
Methods of Use
24 patents (USPTO):Explore Patents

Title: Innovations of Bing Zheng: Pioneering Advances in Therapeutic Antibodies

Introduction: Bing Zheng, based in Mountain View, CA, is an accomplished inventor with an impressive portfolio of 24 patents. His work primarily revolves around the development of therapeutic antibodies and innovative drug conjugates, addressing vital medical needs.

Latest Patents: Among his latest contributions are the patent for "Humanized anti-CD79B antibodies and immunoconjugates and methods of use," which focuses on creating compositions for treating hematopoietic tumors in mammals. Additionally, he has developed a patent titled "Silvestrol antibody-drug conjugates and methods of use." This invention relates to a silvestrol molecule activated with a leaving group and explores a conjugate that combines an antibody with silvestrol drug moieties for effective treatment methodologies.

Career Highlights: Bing Zheng has had significant career advancements, notably working with leading biopharmaceutical companies such as Genentech, Inc. and Genentech. His expertise has played a crucial role in enhancing the efficacy of antibody therapies and associated treatments, particularly in oncology.

Collaborations: Throughout his career, Zheng has collaborated with talented professionals, including Andrew G. Polson and Kristi Elkins. These collaborations have been instrumental in progressing his research and innovations in the field of therapeutic antibodies.

Conclusion: Bing Zheng's contributions to the realm of medicinal chemistry and therapeutic antibodies mark him as a key figure in the industry. His 24 patents reflect not only his innovative spirit but also his commitment to improving patient outcomes through advanced therapeutic solutions. As the field of biotechnology continues to evolve, the impact of Zheng's work will undoubtedly resonate within the medical community for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…